Business Highlights Within the Twelve-Month ended June 30, 2022:
Ms. Marshini Moodley, CEO and CFO, said, “We recorded a decline in both the revenue and gross profit for the period ended
Twelve-month Ending June 30, 2022, Financial Results:
Twelve Months Ended June 30, | ||||||||
2022 | 2021 | |||||||
Revenues | $ | 2,839,357 | $ | 2,969,599 | ||||
Gross Profit | $ | 1,382,624 | $ | 1,748,573 |
Improved Balance Sheet Results
| 2022 | 2021 | ||||||
Cash | $ | 185,782 | $ | 243,610 | ||||
Total Assets | $ | 14,193,235 | $ | 7,157,352 | ||||
Total Liabilities | $ | 9,099,623 | $ | 3,430,326 | ||||
Total Stockholders’ Equity | $ | 5,093,612 | $ | 3,727,026 |
Marshini Moodley added, “Our yearly performance reflecting increased total asset portfolio and total stockholders’ equity. The working capital deficit decreased from
Strategies for Growth
During this financial year we continue to undertake several key activities aimed to improve the overall performance of
- Consolidate the operations of
Prema Life with that ofTugun Compounding Pharmacy to drive cost reduction and efficiencies across both operations. - Launch Health Script telehealth platform for naturopaths globally with key markets focus
Australia and theUSA . - Continue with smaller acquisitions that can contribute to revenue growth and synergies across the group. We expect that the acquisitions made to date will contribute to significant revenue and profit growth this financial year.
These activities are being worked on and we will communicate their completions as we achieve them.
About
For further information, please visit www.rayont.com
SAFE HARBOR
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933, are subject to Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbors created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and other results and further events could differ materially from those anticipated in such statements. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements.
Company Contact:
Investor Relations
ir@rayont.com
Source:
2022 GlobeNewswire, Inc., source